Beyond Weight Loss: GLP-1 Usage and Appetite Regulation in the ... - MDPI
Nov 28, 2025Background: Glucagon-like peptide-1 receptor agonists (GLP-1RAs) have transformed treatment for higher weight and diabetes. Because they also influence appetite and reward processes, these medications may shapeeatingbehaviours, emotions, and body image, raising new challenges foreatingdisorder (ED) research and clinical care. This narrative review synthesises emerging evidence on the ...
source: https://www.mdpi.com